Mathieson was most recently VP and GM of the company’s Acute Care division. She joined Stryker in November 2008 as an account manager. She has since held roles of varying responsibility, including business unit director of Acute Care and sales director.
“Since joining Stryker in 2008, Jessica has exemplified what it means to be an enterprise leader with a strong focus and passion for our culture and fostering an inclusive environment. Under her leadership, her teams have consistently delivered exceptional results, leading to significant growth and global expansion,” Andy Pierce, Stryker president of MedSurg and Neurotechnology, said in a LinkedIn post.
Stryker’s Medical division is part of its MedSurg and Neurotechnology business. Medical generates the most revenue from that business’s four segments, including instruments, endoscopy and neurovascular. In 2022, it reported $3.5 billion in sales, or 17% of Stryker’s total revenue. Stryker Medical’s offerings include patient handling, emergency medical equipment, intensive care disposable products, and clinical communication and workflow services.
“I am thrilled to have her join the MedSurg and Neurotechnology Group Leadership Team and lead Medical’s strategy by partnering with customers to help provide improved outcomes,” Pierce said.
